EpicentRx
PrivateLast Round
Grant
Sep 17, 2024
Total Funding Raised
$47.31M
Company Overview
EpicentRx is a biotechnology company that develops a next-generation immunotherapy platform and small molecule therapies to treat cancer, inflammatory diseases, and other conditions with unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpicentRx Comparables
Compare EpicentRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TILT Biotherapeutics | 81% | |
| BioEclipse Therapeutics | 79% | |
| Lokon Pharma | 79% |
EpicentRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 17, 2024 | ||||
| Grant | Nov 29, 2022 | ||||
| Grant | Jul 12, 2022 | ||||
| Debt | Jan 6, 2021 | ||||
| Series D | Nov 14, 2019 |
EpicentRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FightMND | Grant |
| Shake it Up Australia Foundation | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Congressionally Directed Medical Research Programs | Grant |
| Silicon Valley Bank | Debt |
EpicentRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EpicentRx's valuation, stock price, and market status.
Is EpicentRx a public or private company?
EpicentRx is a private company.
What is the current stock price of EpicentRx?
EpicentRx is a private company with no public stock price. No recent secondary market data is available.
How much is EpicentRx worth (valuation)?
Valuation information for EpicentRx is not publicly available.
Can I buy EpicentRx stock?
EpicentRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EpicentRx's last funding round?
EpicentRx's most recent funding round was Grant on July 12, 2022.
Who are the main investors in EpicentRx?
Key investors in EpicentRx include Silicon Valley Bank.
Will EpicentRx IPO soon?
No public IPO plans have been announced for EpicentRx.
How can I track EpicentRx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EpicentRx's secondary market activity and sign up for updates.